Search

everythinglearnresearchcommunity

for

Search:↓

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

CD2 might be a new treatment target for patchy alopecia areata.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

PUVA treatment is effective and safe for alopecia areata.

Injecting 2 ml of TEEV every 4 weeks is better because it has the same benefits but fewer side effects.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Baricitinib is effective for severe alopecia areata but has some side effects.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.